Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

August 20, 2025

Study Completion Date

August 31, 2026

Conditions
Cervical Ripening
Interventions
DRUG

Misoprostol 25 µg Vaginal

The Misoprostol group (n=40) were Misoprostol cases, a synthetic PGE1 in the form of vaginal tablets of 25 µg (Vagiprost; ADWIA Co/Egypt) applied locally to the posterior fornix every 4 hours for cervical ripening before induction of labor is started (up to 3-doses).

DRUG

Isosorbide Mononitrate

"The Isosorbide Mononitrate group (n=40) were nitric acid donor cases applied to the posterior fornix prior to induction of labor. Isosorbide mononitrate (IMN) (Monomack; Mack Pharmaceutics; Jordan) in a vaginal dose of 40 mg was used every 4 hours (up to 3 doses).~Women who scored a BS of \> 6 from the assigned time were labelled as (1), after the passage of 40 hours, while those women whose BS was less than 6 were labelled (0) for construction of the Kaplan Meier curve for both groups."

Trial Locations (1)

10052

Yarmouk, Baghdad

All Listed Sponsors
lead

Raid M. Al-Ani

OTHER